These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 22383791)

  • 1. Recombinant factor VIIa (rFVIIa) and hemodialysis to manage massive dabigatran-associated postcardiac surgery bleeding.
    Warkentin TE; Margetts P; Connolly SJ; Lamy A; Ricci C; Eikelboom JW
    Blood; 2012 Mar; 119(9):2172-4. PubMed ID: 22383791
    [No Abstract]   [Full Text] [Related]  

  • 2. Life-threatening bleeding in four patients with an unusual excessive response to dabigatran: implications for emergency surgery and resuscitation.
    Lillo-Le Louët A; Wolf M; Soufir L; Galbois A; Dumenil AS; Offenstadt G; Samama MM
    Thromb Haemost; 2012 Sep; 108(3):583-5. PubMed ID: 22782645
    [No Abstract]   [Full Text] [Related]  

  • 3. Dabigatran and bleeding: still an emergent situation?
    Van Heukelom J; Lal Y
    Am J Med Sci; 2013 Sep; 346(3):259. PubMed ID: 23698156
    [No Abstract]   [Full Text] [Related]  

  • 4. Reversal of a dabigatran overdose: what are possible options?
    Ratanapo S; Ungprasert P; Srivali N; Cheungpasitporn W; Bischof EF
    Am J Med Sci; 2013 Sep; 346(3):259. PubMed ID: 23974270
    [No Abstract]   [Full Text] [Related]  

  • 5. The successful management of dabigatran-associated critical end-organ bleeding with recombinant factor VIIa.
    Htun KT; McFadyen J; Tran HA
    Ann Hematol; 2014 Oct; 93(10):1785-6. PubMed ID: 24584995
    [No Abstract]   [Full Text] [Related]  

  • 6. [Dabigatran and emergency operation on a peritonitis patient].
    Ilmakunnas M; Louhimo J; Lassila R
    Duodecim; 2012; 128(7):753-7. PubMed ID: 22612026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dabigatran and its reversal with recombinant factor VIIa and prothrombin complex concentrate: a Sonoclot in vitro study.
    Sølbeck S; Nilsson CU; Engström M; Ostrowski SR; Johansson PI
    Scand J Clin Lab Invest; 2014 Oct; 74(7):591-8. PubMed ID: 24909158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of recombinant factor VIIa on thrombin generation and thromboelastography in a patient with dabigatran-associated intracranial hemorrhage.
    Aron JL; Gosselin R; Moll S; Arkin CF; Mantha S
    J Thromb Thrombolysis; 2014; 37(2):76-9. PubMed ID: 23519385
    [No Abstract]   [Full Text] [Related]  

  • 9. Type A aortic dissection in a patient on dabigatran: hemostasis post circulatory arrest.
    Ashikhmina E; Tomasello N; Connors JM; Jahanyar J; Davidson M; Mizuguchi KA
    Ann Thorac Surg; 2014 Dec; 98(6):2215-6. PubMed ID: 25468095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodialysis for the treatment of pulmonary hemorrhage from dabigatran overdose.
    Chen BC; Sheth NR; Dadzie KA; Smith SW; Nelson LS; Hoffman RS; Winchester JF
    Am J Kidney Dis; 2013 Sep; 62(3):591-4. PubMed ID: 23597859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of intermittent and continuous extracorporeal treatments for the enhanced elimination of dabigatran.
    Bouchard J; Ghannoum M; Bernier-Jean A; Williamson D; Kershaw G; Weatherburn C; Eris JM; Tran H; Patel JP; Roberts DM
    Clin Toxicol (Phila); 2015 Mar; 53(3):156-63. PubMed ID: 25661675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The acute management of haemorrhage, surgery and overdose in patients receiving dabigatran.
    Alikhan R; Rayment R; Keeling D; Baglin T; Benson G; Green L; Marshall S; Patel R; Pavord S; Rose P; Tait C
    Emerg Med J; 2014 Feb; 31(2):163-8. PubMed ID: 23435652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracorporeal therapy for dabigatran removal in the treatment of acute bleeding: a single center experience.
    Singh T; Maw TT; Henry BL; Pastor-Soler NM; Unruh ML; Hallows KR; Nolin TD
    Clin J Am Soc Nephrol; 2013 Sep; 8(9):1533-9. PubMed ID: 23704302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of dabigatran-induced bleeding: expert statement.
    Fries D; Giurea A; Gütl M; Halbmayer WM; Kozek-Langenecker S; Pachucki A; Roithinger F; Steinlechner B; Thaler H; Weltermann A
    Wien Klin Wochenschr; 2013 Nov; 125(21-22):721-9. PubMed ID: 24217941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Managing bleeding complications in patients treated with the old and the new anticoagulants.
    Romualdi E; Rancan E; Siragusa S; Ageno W
    Curr Pharm Des; 2010; 16(31):3478-82. PubMed ID: 20858186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dabigatran-induced acute hepatitis.
    Rochwerg B; Xenodemetropoulos T; Crowther M; Spyropoulos A
    Clin Appl Thromb Hemost; 2012 Sep; 18(5):549-50. PubMed ID: 22962308
    [No Abstract]   [Full Text] [Related]  

  • 17. What is the role of hemodialysis for dabigatran-associated major bleeding?
    Kim B; Garcia DA
    Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):514-7. PubMed ID: 25696903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How I treat target-specific oral anticoagulant-associated bleeding.
    Siegal DM; Garcia DA; Crowther MA
    Blood; 2014 Feb; 123(8):1152-8. PubMed ID: 24385535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dabigatran, bleeding, and the regulators.
    Moore TJ; Cohen MR; Mattison DR
    BMJ; 2014 Jul; 349():g4517. PubMed ID: 25056265
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hemodialysis to remove anticoagulant dabigatran during emergencies].
    Carrizo A; Campbell S
    Medicina (B Aires); 2014; 74(2):121-3. PubMed ID: 24736256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.